Human Longevity Revenue and Competitors
Estimated Revenue & Valuation
- Human Longevity's estimated annual revenue is currently $15.3M per year.
- Human Longevity received $220.0M in venture funding in April 2016.
- Human Longevity's estimated revenue per employee is $155,000
- Human Longevity's total funding is $330M.
- Human Longevity's current valuation is $1.2B.
Employee Data
- Human Longevity has 99 Employees.
- Human Longevity grew their employee count by -6% last year.
Human Longevity's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Cardiac Sonographer | Reveal Email/Phone |
2 | VP, Product Development | Reveal Email/Phone |
3 | VP, Data Engineering | Reveal Email/Phone |
4 | Director medical genomics | Reveal Email/Phone |
5 | Imaging Director | Reveal Email/Phone |
6 | Chief Medical Officer Human Longevity Inc./Medical Director Human Longevity San Francisco | Reveal Email/Phone |
7 | Chief Commercial Officer | Reveal Email/Phone |
8 | President/Chief Innovation Officer | Reveal Email/Phone |
9 | Lab Director | Reveal Email/Phone |
10 | Technical Imaging Director | Reveal Email/Phone |
Human Longevity Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Human Longevity?
Human Longevity, Inc. ™ (HLI) is the genomics-based, health intelligence company creating the world's largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries from these data to generate personalized health insights. Our goal is to extend healthy human life by revolutionizing human health and transforming the practice of medicine. Our DNA determines so much about each of us, but other factors can also influence our health. HLI is focused on compiling and analyzing more genotypic and phenotypic data because the combination of both enables us —to generate unprecedented insights and accelerate our understanding into what makes us who we are and what we can change for a life better lived.
keywords:Analytics,Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals
$330M
Total Funding
99
Number of Employees
$15.3M
Revenue (est)
-6%
Employee Growth %
$1.2B
Valuation
N/A
Accelerator
Human Longevity News
The average life expectancy for a sickle cell patient is 42-47 years ... the science that will take us to the limits of human longevity.
Dorian Gray, Wolverine and Peter Pan ahead of the Longevity Leaders ... human lifespan and healthspan and delivering healthy aging.
ETP Ventures, Human Longevity and Performance Impact Venture Fund, BOLD Capital Partners, Longevity Vision Fund, LongeVC, co-founder of...
Longevity has become a space of growing interest, with many big names ... into research, big data and companies trying to extend human life.
Billionaire Backs U.K. Startup Trying To Extend Human Life Spans ... in Juvenescence, a U.K. firm that's trying to increase human longevity.
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $17.8M | 99 | 25% | N/A |
#2 | $15M | 99 | -4% | N/A |
#3 | $26.7M | 99 | 5% | N/A |
#4 | $35M | 99 | 50% | N/A |
#5 | $7.5M | 99 | 25% | N/A |
Human Longevity Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2014-03-05 | $70.0M | Undisclosed | Synthetic Genomics | Article |
| 2016-04-05 | $220.0M | B | Illumina | Article |